OpenEvidence closed a $250 million funding round, doubling its valuation to $12 billion as its ad-supported AI tool gains traction with US physicians.
The company is positioning this approach as a turning point for robotics, comparable to what large generative models have done for text and images.
Most athletes play ping pong to whet their competitive instincts or kill time. But what if it could actually improve ...